HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bayer Suggests Self-Care Industry Follow Five Principles As 'Blueprint' For Product Development

Executive Summary

Bayer proposes five science-based principles to guide industry’s self-care research and development to reframe self-care and earn consumer trust.

You may also be interested in...

Bayer Places Consumer Cost Of Living Pressures 'Very High' On Agenda

Despite spiraling inflation, branded OTC product demand remains high, according to Bayer Consumer Health, which posted Q2 sales up by 16.0%. But with consumer incomes increasingly squeezed, the company is working on ways to defend its market share against cheaper private-label alternatives.

Over The Counter 26 July 2022: Global Self-Care Trends With J&J Self-Care R&D Lead Adam Ricciardone

In this episode, HBW Insight speaks to Johnson & Johnson Self-Care R&D lead Adam Ricciardone about four macro trends the company is observing worldwide: total wellness, sustainability, demographic shifts and the “techceleration” of self-care. Ricciardone talks about J&J's latest self-care technologies and why non-western countries, particularly in Asia, are quicker to adopt new consumer healthcare trends. 

Self-Care Saving Taxpayers $120bn Per Year, Could Increase To $180bn By 2030

Self-care practices could save healthcare systems about $180bn a year, individuals 18bn hours a year, and increase productivity by 72bn extra workdays by 2030 if the right policies are implemented, argues a new report by the Global Self-Care Federation. 

Related Content


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts